Higher Levels of Galectin-1 and Galectin-3 in Young Subjects with Autism Spectrum Disorder Compared to Unaffected Siblings and Healthy Controls

Overview

Journal Clin Psychopharmacol Neurosci

Specialty Psychiatry

Date 2023 Oct 20

PMID 37859448

Authors

Zeynep Nur Karadogan

Yasar Tanir

Ali Karayagmurlu

Canan Kucukgergin

Murat Coskun

Affiliations

Soon will be listed here.

Abstract

Objective: : Despite being highly genetic, the etiology of autism spectrum disorder (ASD), has not yet been clarified. Recent research has focused on the role of neuroinflammation and immune system dysfunction in the pathophysiology of neurodevelopmental disorders including ASD. Galectin-1 and galactin-3 are considered among the biomarkers of neuroinflammation and there has been recent reports on the potential role of galectins in the etiology of neurodevelopmental disorders. However, there has been no study examining the relationship between ASD and galectin levels.

Methods: : Current study aimed to investigate galectin-1 and galectin-3 serum levels in young subjects with ASD comparing with their unaffected siblings and healthy controls.

Results: : We found significantly higher levels of galectin-1 in case group compared to both unaffected siblings and healthy controls, and higher levels of galectin-3 in case group compared to healthy controls. However, there was no significant association between galectin-1 and galectin-3 levels with the severity of ASD.

Conclusion: : Findings of our study may support neuroinflammation hypothesis in the etiology of ASD and the potential role of galectin-1 and galectin-3 as biomarkers.

References

Shin T . The pleiotropic effects of galectin-3 in neuroinflammation: a review. Acta Histochem. 2013; 115(5):407-11. DOI: 10.1016/j.acthis.2012.11.010. View

Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah I, Van de Water J . Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav Immun. 2010; 25(1):40-5. PMC: 2991432. DOI: 10.1016/j.bbi.2010.08.003. View

Suzuki K, Sugihara G, Ouchi Y, Nakamura K, Futatsubashi M, Takebayashi K . Microglial activation in young adults with autism spectrum disorder. JAMA Psychiatry. 2013; 70(1):49-58. DOI: 10.1001/jamapsychiatry.2013.272. View

Lucchina L, Depino A . Altered peripheral and central inflammatory responses in a mouse model of autism. Autism Res. 2013; 7(2):273-89. DOI: 10.1002/aur.1338. View

Salatino M, Croci D, Bianco G, Ilarregui J, Toscano M, Rabinovich G . Galectin-1 as a potential therapeutic target in autoimmune disorders and cancer. Expert Opin Biol Ther. 2007; 8(1):45-57. DOI: 10.1517/14712598.8.1.45. View

Sciacchitano S, Lavra L, Morgante A, Ulivieri A, Magi F, De Francesco G . Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z. Int J Mol Sci. 2018; 19(2). PMC: 5855601. DOI: 10.3390/ijms19020379. View

Chez M, Guido-Estrada N . Immune therapy in autism: historical experience and future directions with immunomodulatory therapy. Neurotherapeutics. 2010; 7(3):293-301. PMC: 5084233. DOI: 10.1016/j.nurt.2010.05.008. View

Shen L, Liu X, Zhang H, Lin J, Feng C, Iqbal J . Biomarkers in autism spectrum disorders: Current progress. Clin Chim Acta. 2019; 502:41-54. DOI: 10.1016/j.cca.2019.12.009. View

Desmedt V, Desmedt S, Delanghe J, Speeckaert R, Speeckaert M . Galectin-3 in Renal Pathology: More Than Just an Innocent Bystander. Am J Nephrol. 2016; 43(5):305-17. DOI: 10.1159/000446376. View

10.

Xu N, Li X, Zhong Y . Inflammatory cytokines: potential biomarkers of immunologic dysfunction in autism spectrum disorders. Mediators Inflamm. 2015; 2015:531518. PMC: 4333561. DOI: 10.1155/2015/531518. View

11.

Calcia M, Bonsall D, Bloomfield P, Selvaraj S, Barichello T, Howes O . Stress and neuroinflammation: a systematic review of the effects of stress on microglia and the implications for mental illness. Psychopharmacology (Berl). 2016; 233(9):1637-50. PMC: 4828495. DOI: 10.1007/s00213-016-4218-9. View

12.

Wu L, Zhao Q, Zhu X, Peng M, Jia C, Wu W . A novel function of microRNA let-7d in regulation of galectin-3 expression in attention deficit hyperactivity disorder rat brain. Brain Pathol. 2010; 20(6):1042-54. PMC: 8094722. DOI: 10.1111/j.1750-3639.2010.00410.x. View

13.

Erden S, Nalbant K, Kilinc I . Investigation of Relaxin-3 Serum Levels in terms of Social Interaction, Communication, and Appetite as a Biomarker in Children with Autism. Clin Psychopharmacol Neurosci. 2022; 20(1):135-142. PMC: 8813315. DOI: 10.9758/cpn.2022.20.1.135. View

14.

McGraw J, Gaudet A, Oschipok L, Kadoya T, Horie H, Steeves J . Regulation of neuronal and glial galectin-1 expression by peripheral and central axotomy of rat primary afferent neurons. Exp Neurol. 2005; 195(1):103-14. DOI: 10.1016/j.expneurol.2005.04.004. View

15.

Chez M, Dowling T, Patel P, Khanna P, Kominsky M . Elevation of tumor necrosis factor-alpha in cerebrospinal fluid of autistic children. Pediatr Neurol. 2007; 36(6):361-5. DOI: 10.1016/j.pediatrneurol.2007.01.012. View

16.

Elola M, Wolfenstein-Todel C, Troncoso M, Vasta G, Rabinovich G . Galectins: matricellular glycan-binding proteins linking cell adhesion, migration, and survival. Cell Mol Life Sci. 2007; 64(13):1679-700. PMC: 11136145. DOI: 10.1007/s00018-007-7044-8. View

17.

Schopler E, Reichler R, DeVellis R, Daly K . Toward objective classification of childhood autism: Childhood Autism Rating Scale (CARS). J Autism Dev Disord. 1980; 10(1):91-103. DOI: 10.1007/BF02408436. View

18.

Caniglia J, Asuthkar S, Tsung A, Guda M, Velpula K . Immunopathology of galectin-3: an increasingly promising target in COVID-19. F1000Res. 2020; 9:1078. PMC: 7536583. DOI: 10.12688/f1000research.25979.2. View

19.

Tetreault N, Hakeem A, Jiang S, Williams B, Allman E, Wold B . Microglia in the cerebral cortex in autism. J Autism Dev Disord. 2012; 42(12):2569-84. DOI: 10.1007/s10803-012-1513-0. View

20.

. Prevalence of autism spectrum disorders--Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008. MMWR Surveill Summ. 2012; 61(3):1-19. View